Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs62054624 | chr16:90103451 | C/T | 8.73E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs62054638 | chr16:89821131 | G/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054639 | chr16:89821489 | C/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054640 | chr16:89823157 | C/T | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054642 | chr16:89829427 | G/A | 0.000167 | 177 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054643 | chr16:89829455 | A/G | 0.000167 | 177 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054644 | chr16:89829835 | C/G | 0.000167 | 177 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs62054659 | chr16:90148397 | C/G | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs62056060 | chr16:89900502 | G/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056061 | chr16:89901767 | G/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056063 | chr16:89903680 | C/T | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056064 | chr16:89903843 | G/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056065 | chr16:89905115 | C/G | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056066 | chr16:89906563 | G/A | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs62056068 | chr16:89909737 | C/T | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |